Longevity Health Holdings Statistics
Total Valuation
XAGE has a market cap or net worth of $3.83 million. The enterprise value is $4.67 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, before market open.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XAGE has 30.12 million shares outstanding. The number of shares has increased by 93.83% in one year.
| Current Share Class | 30.12M |
| Shares Outstanding | 30.12M |
| Shares Change (YoY) | +93.83% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 11.30% |
| Owned by Institutions (%) | 17.02% |
| Float | 26.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 64.97 |
| Forward PS | n/a |
| PB Ratio | -0.89 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 92.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16
| Current Ratio | 0.16 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -101.98 |
Financial Efficiency
Return on equity (ROE) is -106.31% and return on invested capital (ROIC) is -27.39%.
| Return on Equity (ROE) | -106.31% |
| Return on Assets (ROA) | -9.55% |
| Return on Invested Capital (ROIC) | -27.39% |
| Return on Capital Employed (ROCE) | 113.53% |
| Revenue Per Employee | $3,355 |
| Profits Per Employee | -$691,217 |
| Employee Count | 15 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -97,279 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.80% in the last 52 weeks. The beta is 0.71, so XAGE's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -93.80% |
| 50-Day Moving Average | 0.17 |
| 200-Day Moving Average | 0.39 |
| Relative Strength Index (RSI) | 38.48 |
| Average Volume (20 Days) | 16,221,701 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XAGE had revenue of $50,318 and -$10.37 million in losses. Loss per share was -$0.49.
| Revenue | 50,318 |
| Gross Profit | 43,961 |
| Operating Income | -5.00M |
| Pretax Income | n/a |
| Net Income | -10.37M |
| EBITDA | -4.92M |
| EBIT | -5.00M |
| Loss Per Share | -$0.49 |
Full Income StatementBalance Sheet
The company has $157,139 in cash and $638,993 in debt, giving a net cash position of -$481,854 or -$0.02 per share.
| Cash & Cash Equivalents | 157,139 |
| Total Debt | 638,993 |
| Net Cash | -481,854 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | -4.71M |
| Book Value Per Share | -0.23 |
| Working Capital | -4.92M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.39M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.39M |
| FCF Per Share | -$0.15 |
Full Cash Flow StatementMargins
| Gross Margin | 87.37% |
| Operating Margin | -9,933.82% |
| Pretax Margin | -21,359.64% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |